Technical analysis of Natera, Inc. (NTRA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders by screening for specific single-gene mutations.
Price Performance
| 1 month | +5.49% |
| 3 months | +62.83% |
| Year-to-date | +90.32% |
| 1 year | +125.65% |
| 3 years | +1004.64% |
| 5 years | +280.55% |
| 10 years | +5121.56% |
52-Week Range
| 52-week High | $436.94 |
| 52-week Low | $181.00 |
| Avg Volume (90d) | 1.5M |
Technical Indicators
| SMA 50 | $375.27 |
| SMA 200 | $265.27 |
| Beta | 1.68 |
| 30-day Volatility (annualised) | 36.0% |
| Price vs SMA 50 | +16.2% |
| Price vs SMA 200 | +64.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $229.09 | |
| 2026-01 | $231.14 | +0.9% |
| 2026-02 | $208.04 | -10.0% |
| 2026-03 | $199.99 | -3.9% |
| 2026-04 | $206.16 | +3.1% |
| 2026-05 | $223.37 | +8.3% |
| 2026-06 | $271.45 | +21.5% |
| 2026-07 | $267.76 | -1.4% |
| 2026-08 | $321.96 | +20.2% |
| 2026-08 | $321.96 | +0.0% |
| 2026-09 | $413.31 | +28.4% |
| 2026-10 | $436.00 | +5.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-05 | $-0.28 | $708M |
| 2026-08-06 | $-0.49 | $661M |
| 2026-05-07 | $-0.54 | $617M |
| 2026-02-26 | $-0.51 | $604M |
| 2025-11-06 | $-0.39 | $513M |
| 2025-08-07 | $-0.62 | $476M |
| 2025-05-08 | $-0.64 | $446M |
Price
| Price | $403.95 (closing price, October 29, 2026) |
| Market Cap | $58.2B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 34.30 |
| EV / EBITDA | -346.90 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.13 |
| Current Ratio | 3.00 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 23.09 |